RADIATION · Unmapped registry intervention
High Dose brachytherapy boost
Find medicine records ·
Find other trials using this name
Clinical trial
Radiation Therapy in Treating Patients With Stage II or Stage III Prostate Cancer
NCT00091390
Drugs and interventions used in this trial
2 registeredThese interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.
RADIATION · Unmapped registry intervention
External beam radiotherapy
Find medicine records ·
Find other trials using this name
No matching interventions in this trial.
Study at a glance
Registry-backedRadiation Therapy in Treating Patients With Stage II or Stage III Prostate Cancer
Design: INTERVENTIONAL · Status: COMPLETED · Phase: PHASE2
Read study objectives, eligibility and outcome measures at ClinicalTrials.govAdvertisement
Conditions
Prostate Cancerverified · MONDO: prostate cancer
Interventions
High Dose brachytherapy boostRADIATION
External beam radiotherapyRADIATION
Sponsors & collaborators
Radiation Therapy Oncology Grouplead sponsor
National Cancer Institute (NCI)collaborator
NRG Oncologycollaborator
Mapped research locations
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT00091390 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.